有关新型冠状病毒的线上研讨会：检测与追踪方面的突破
随着新型冠状病毒在美国的感染人数增速逐渐放缓，医学专家们与政府决策人员开始考虑对今年下半年的预期以及恢复日常生活所需的措施。
Rochelle Walensky, MD, MPH
Rochelle Walensky, MD, MPH
Chief, Division of Infectious Diseases
Professor of Medicine, Harvard Medical School
Professor of Medicine, Harvard Medical School
About Rochelle Walensky, MD, MPH
Dr. Rochelle Walensky, MD, MPH, is Professor of Medicine at Harvard Medical School and a practicing Infectious Disease physician at Massachusetts General Hospital and Brigham and Women's Hospital.
Dr. Walensky's research interests focus on model-based analyses of the cost-effectiveness of HIV testing, care, and prevention strategies to inform HIV/AIDS policy internationally and domestically.
Using both traditional novel methods of microsimulation modeling and decision analysis, Dr. Walensky has been active in and nationally recognized for motivating health policy and informing clinical trial design and evaluation in a variety of settings.
In addition, Dr. Walensky has been influential in advancing international health policy towards the promotion of HIV treatment as prevention (TasP) and the adoption of other effective and efficient strategies of HIV care.
Dr. Walensky serves as Chair of the Office of AIDS Research Advisory Council (NIH) and as a member of the US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents.
Clinical Interests:
- AIDS and HIV infection
- Infectious diseases
Treats:
- Adult
Locations
Infectious Disease Associates
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-3467
Medical Education
- Harvard T. H Chan School of Public Health
- MD, Johns Hopkins University School of Medicine
- Residency, Johns Hopkins University School of Medicine
- Residency, The Johns Hopkins Hospital
- Fellowship, Brigham and Women's/Massachusetts General Joint Nephrology Fellowship
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Infectious Disease, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- MassHealth
- Medicare
- Medicare - ACD
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - New York
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Rochelle Walensky, MD, MPH, is the Chief of Infectious Diseases at MGH and Professor of Medicine at Harvard Medical School. Dr. Walensky’s research interests have focused on HIV/AIDS policy and cost-effective strategies of HIV care in the US and in resource-limited settings; she is internationally recognized for motivating US and global policy toward routine HIV screening. She is a member of the American Society for Clinical Investigation, the American Association of Physicians, and the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, and she is past Chair of the NIH Office of AIDS Research Advisory Council. She has also been an advisor to the WHO and UNAIDS. Dr. Walensky received her M.D. from the Johns Hopkins School of Medicine and her M.P.H. from the Harvard School of Public Health. She trained in Internal Medicine at the Johns Hopkins Hospital and in Infectious Diseases at the MGH/BWH combined fellowship program.
Publications
-
View my most recent publications at PubMed
Selected References:
- Walensky RP, Sax PE, Nakamura YM, Weinstein MC, Pei PP, Freedberg KA, Paltiel AD, Schackman BR. Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States. Ann Intern Med. 2013 Jan 15; 158(2):84-92.
- Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Want L, McCauley M, Gamble T, Seage GR, Cohen MS, Freedberg KA. The cost-effectiveness of HIV treatment as prevention: analysis of HPTN 052. N Eng J Med. 2013; 369(18):1715–1725.